☆ 4.0 Letter

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia

TURKISH JOURNAL OF HEMATOLOGY (2013)

Journal

TURKISH JOURNAL OF HEMATOLOGY

Volume 30, Issue 2, Pages 211-213

Publisher

GALENOS YAYINCILIK

DOI: 10.4274/Tjh.2012.0013

Keywords

-

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.